Batch BeaconUK recalls and safety alerts

Medicines recallMHRA

Mynzepli 40 mg/mL solution for injection in pre-filled syringe recalled over a packaging defect

Packaging or device defectHigh riskClass 2

Advanz Pharma Limited are recalling specified batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringe as a precautionary measure.

Check your product

Only products that match these details are covered. Have your pack in front of you.

6 identifiers listed for this notice.

  • Mynzepli 40 mg/mL solution for injection in pre-filled syringe 1

    Batch codePrinted on the pack, often next to the date mark. It may start with L or LOT.
    • 2325742
    • 2325726
    ExpiryOn the carton, blister or label.
    • Jun-2027
    • May-2027
    First distributedOn the product, its label or its packaging.
    • 02/01/2026
    • 10/10/2025

What to do now

A fault with the packaging or delivery device of Mynzepli 40 mg/mL solution for injection in pre-filled syringe has been found.

  1. Do not stop taking a prescribed medicine without advice: missing doses can be more dangerous than the defect.
  2. Compare the batch number printed on the box or label with the batches listed here.
  3. If your pack is affected, take it to your pharmacy or contact the prescriber for a replacement.
  4. Any side effect you think is linked can be reported through the Yellow Card scheme.

Why it matters. A faulty cap, seal, syringe or inhaler can mean a missed or wrong dose, or contamination of the product.

Symptoms and when to get help

Look out for

  • a side effect you have not had before
  • your condition not being controlled as well as usual

Get help urgently

  • signs of a severe allergic reaction, such as swelling of the face or throat or difficulty breathing — call 999
  • if you feel unwell and are worried, speak to a pharmacist, your GP or NHS 111

This is general information based on NHS public guidance, not medical advice. In an emergency call 999. For urgent advice use NHS 111 (NHS 24 on 111 in Scotland) or, in Northern Ireland, your GP or out-of-hours service.

Replacements and prescriptions

If your pack is affected, your pharmacy can usually exchange it for an unaffected batch or another suitable product. Prescription medicines are replaced through your pharmacy or prescriber; you do not need to buy a new supply yourself.

Many recalls are made at pharmacy or wholesaler level and do not require patients to act. The notice says which level applies.

From the official notice

Published by the Medicines and Healthcare products Regulatory Agency (EL(26)A/44). Quoted as issued.

Summary

Advanz Pharma Limited are recalling specified batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringe as a precautionary measure.

The risk

DMRC reference number DMRC - 41252013 Marketing Authorisation Holder

Advice for healthcare professionals

Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Advanz Pharma have confirmed that other unaffected batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringe are currently available for distribution.

This is a Pharmacy and Wholesaler level recall, therefore no further action is required by patients.

This product is only administered by a qualified healthcare professional experienced in administering intravitreal injections.

Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Advice for patients

This is a Pharmacy and Wholesaler level recall, therefore no further action is required by patients.

This product is only administered by a qualified healthcare professional experienced in administering intravitreal injections.

Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Open the MHRA notice

Questions

Why has Mynzepli 40 mg/mL solution for injection in pre-filled syringe been recalled?

A fault with the packaging or delivery device of Mynzepli 40 mg/mL solution for injection in pre-filled syringe has been found. A faulty cap, seal, syringe or inhaler can mean a missed or wrong dose, or contamination of the product.

How do I know if my medicine is affected?

Compare the batch code, expiry and date code on your pack with the details listed under “Check your product” on this page. Only items that match are covered by the notice.

What should I do now?

Do not stop taking a prescribed medicine without advice: missing doses can be more dangerous than the defect. Compare the batch number printed on the box or label with the batches listed here.

Do I need a new prescription?

If your pack is affected, your pharmacy can usually exchange it for an unaffected batch or another suitable product. Prescription medicines are replaced through your pharmacy or prescriber; you do not need to buy a new supply yourself. Many recalls are made at pharmacy or wholesaler level and do not require patients to act. The notice says which level applies.

Related notices